A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/06/2011	WO2011121160A1 Pharmaceutical formulation based on ibuprofen and codeine having having improved stability
10/06/2011	WO2011121074A1 Thermogelling anaesthetic compositions
10/06/2011	WO2011120924A1 Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
10/06/2011	WO2011120859A1 Fusion protein and its uses
10/06/2011	WO2011120704A1 Transdermal patch containing 17-deacetyl norgestimate
10/06/2011	WO2011120156A1 Polyamine-containing polymers and methods of synthesis and use
10/06/2011	WO2011120155A1 Supercritical fluid treatment of high molecular weight biopolymers
10/06/2011	WO2011120084A1 Transdermal delivery patch
10/06/2011	WO2011120070A1 Transdermal delivery patch
10/06/2011	WO2011077452A3 Fast dissolving pharmaceutical composition comprising lornoxicam
10/06/2011	WO2011063164A3 Sustained release cannabinoid medicaments
10/06/2011	WO2011061519A3 Topical foam composition
10/06/2011	WO2011050357A3 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
10/06/2011	WO2011044533A3 Coating system and method for drug elution management
10/06/2011	WO2011037349A3 Target specific drug delivery system, target non-specific long-acting drug delivery system and method of controlling target specificity thereof
10/06/2011	WO2011035279A3 Nanocarriers for imaging and therapy applications
10/06/2011	WO2011031996A3 Engineered microparticles for macromolecule delivery
10/06/2011	WO2011020107A3 Compositions and methods for detection and treatment of breast cancer
10/06/2011	WO2010121130A3 Molecular delivery with nanowires
10/06/2011	WO2010111221A4 Compositions and methods for preferential distribution of active agents to injury sites
10/06/2011	US20110245784 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues
10/06/2011	US20110245472 Method for the mass production of immunoglobulin constant region
10/06/2011	US20110245353 Sweet flavor modifier
10/06/2011	US20110245352 Composition For Permeabilizing The Walls Of Microorganisms Comprising The Combination Of Ethylenediaminetetraacetic Acid (EDTA) And Polyethyleneimine (PEI)
10/06/2011	US20110245351 Medical adhesive for surgery
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245202 Pharmaceutical composition for the treatment of rhinitis
10/06/2011	US20110245177 Method for topical treatment of eye disease and composition and device for said treatment
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110245147 Activation of Peptide Prodrugs by HK2
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244046 Charge Reversible Polymers
10/06/2011	US20110244032 Dispersible phospholipid stabilized microparticles
10/06/2011	US20110244031 Porous tablets as carriers for liquid formulations
10/06/2011	US20110244030 Topical foaming compositon and method of application
10/06/2011	US20110244023 Transdermal delivery patch
10/06/2011	US20110244005 Controlled release cgrp delivery composition for cardiovascular and renal indications
10/06/2011	US20110244004 Antifungal composition with enhanced bioavailability
10/06/2011	US20110243969 Production of squalene from hyper-producing yeasts
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243892 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
10/06/2011	US20110243883 Polymeric biolubricants for medical use
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243880 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	DE102010003615A1 Verfahren zur Herstellung eines Drug-Delivery-Systems auf der Basis von Polyelektrolytkomplexen A process for the preparation of a drug delivery system based on polyelectrolyte complexes
10/06/2011	CA2830052A1 Injectable dendrimer hydrogel nanoparticles
10/06/2011	CA2795291A1 An insulin conjugate using an immunoglobulin fragment
10/06/2011	CA2795158A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/06/2011	CA2795154A1 Thermogelling anaesthetic compositions
10/06/2011	CA2795084A1 Polyamine-containing polymers and methods of synthesis and use
10/06/2011	CA2795047A1 Excipients for stabilising viral particles, polypeptides or biological material
10/06/2011	CA2795013A1 Stabilisation of viral particles
10/06/2011	CA2794960A1 Supercritical fluid treatment of high molecular weight biopolymers
10/06/2011	CA2794958A1 Injectable drug delivery formulation
10/06/2011	CA2794956A1 Medical devices including medicaments and methods of making and using same
10/06/2011	CA2794734A1 Transdermal delivery patch
10/06/2011	CA2794631A1 Stabilized antibody preparations and uses thereof
10/06/2011	CA2794628A1 Stabilized antibody preparations and uses thereof
10/06/2011	CA2794555A1 Improved treatment of renal cell carcinoma
10/06/2011	CA2794499A1 Antibody-based depletion of antigen-presenting cells and dendritic cells
10/06/2011	CA2794308A1 Hypersulfated glucopyranosides
10/06/2011	CA2793777A1 Formulations of mazindol
10/06/2011	CA2793580A1 Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
10/06/2011	CA2793405A1 A fast dissolving pharmaceutical composition
10/06/2011	CA2792068A1 Sweet flavor modifier
10/05/2011	EP2371844A1 Chimeric surface active proteins
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2371388A2 Antibody formulations
10/05/2011	EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011	EP2371368A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions
10/05/2011	EP2371365A1 Compositions comprising an epothilone and production methods
10/05/2011	EP2371364A1 Topical or intravenous co-enzyme Q10 formulations for use in treating cancer
10/05/2011	EP2371363A1 Coenzyme Q10 formulations for use in the treatment of solid tumours
10/05/2011	EP2371362A1 Co-enzyme Q10 formulations for treating cancer by intravenous administration
10/05/2011	EP2371360A2 Selegiline-containing adhesive preparation
10/05/2011	EP2371359A2 Selegiline-containing adhesive preparation
10/05/2011	EP2371353A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
10/05/2011	EP2370574A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation
10/05/2011	EP2370501A1 Synthesis of obtaining modified polyethylene glycol intermediates
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370406A1 High penetration compositions and their applications
10/05/2011	EP2370107A2 Selective anticancer chimeric peptide
10/05/2011	EP2370106A2 Active ingredient-peptide construct for extracellular enrichment
10/05/2011	EP2370105A2 Transport-mediating colloidal pharmaceutical compounds
10/05/2011	EP2370104A1 Peptides for treatment of obesity
10/05/2011	EP2370068A2 Methods and compositions for delivery of medicaments to the lungs
10/05/2011	EP2370063A2 Flowable pharmaceutical depot
10/05/2011	EP2370059A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
10/05/2011	EP2370056A2 Enema preparations and their use
10/05/2011	EP1948245B1 Compositions and their uses for gene therapy of bone conditions
10/05/2011	EP1920786B1 Oral preparation for measuring pyrimidine metabolic capacity
10/05/2011	EP1913026B1 Modified antibody fragments
10/05/2011	EP1874352B1 Photodynamic therapy using chemoluminescence and a ligand-photosensitiser conjugate
10/05/2011	EP1848804B1 Anti-muc1 alpha beta antibodies
10/05/2011	EP1687267B1 Modified mscl protein channel
10/05/2011	EP1680144B1 Methylphenidate solution and associated methods of administration and production

1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 1712